폐 침범을 동반한 상기도의 재발성 호흡기 유두종증 소아 환자에서 정맥 내 시도포비어 사용 1예
Intravenous cidofovir as an adjuvant therapy for recurrent upper airway papillomatosis with lung involvement in a child
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Recurrent respiratory papillomatosis (RRP) is a chronic disease related to human papillomavirus infection. The standard treatment of RRP is surgical resection of the lesion, but due to frequent recurrence, a combination of various adjuvant therapies has been attempted. Herein, we present the first case of RRP to whom intravenous cidofovir was administered as an adjuvant therapy in Korea. A 9-year-old boy was admitted due to hoarseness, stridor and breathing difficulty. At 10 months of age, he was diagnosed with RRP in the upper airway and thereafter he had repeatedly undergone surgical removal. During this hospitalization, papilloma was found again from the superior glottis to the inferior glottis and surrounding the trachea at the age of 9 years. In addition, well-defined nodular lesions were newly found on both lung fields, and a pathologic examination revealed a squamous papilloma with high-grade dysplasia, human papilloma virus types 6, 11, and 40 (low-risk type). Because of the frequent recurrence of papilloma in the upper airway as well as lung involvement, he underwent 38 injections of intravenous cidofovir for 2 years. During treatment, the intervals required for surgical removal of the mass causing upper airway obstruction were prolonged from an average of 37.3 to 74.6 days without serious side effects. However, intravenous cidofovir treatment had no effect on the lung lesion. This case shows that an intravenous cidofovir administration can be used as an adjuvant therapy in a child with RRP to relieve the upper airway obstruction, although this treatment does not cure the disease.
Abstract
Recurrent respiratory papillomatosis (RRP) is a chronic disease related to human papillomavirus infection. The standard treatment of RRP is surgical resection of the lesion, but due to frequent recurrence, a combination of various adjuvant therapies has been attempted. Herein, we present the first case of RRP to whom intravenous cidofovir was administered as an adjuvant therapy in Korea. A 9-year-old boy was admitted due to hoarseness, stridor and breathing difficulty. At 10 months of age, he was diagnosed with RRP in the upper airway and thereafter he had repeatedly undergone surgical removal. During this hospitalization, papilloma was found again from the superior glottis to the inferior glottis and surrounding the trachea at the age of 9 years. In addition, well-defined nodular lesions were newly found on both lung fields, and a pathologic examination revealed a squamous papilloma with high-grade dysplasia, human papilloma virus types 6, 11, and 40 (low-risk type). Because of the frequent recurrence of papilloma in the upper airway as well as lung involvement, he underwent 38 injections of intravenous cidofovir for 2 years. During treatment, the intervals required for surgical removal of the mass causing upper airway obstruction were prolonged from an average of 37.3 to 74.6 days without serious side effects. However, intravenous cidofovir treatment had no effect on the lung lesion. This case shows that an intravenous cidofovir administration can be used as an adjuvant therapy in a child with RRP to relieve the upper airway obstruction, although this treatment does not cure the disease.
참고문헌 (15)
- Seedat RY, "Juvenile-onset recurrent respiratory papillomatosis diagnosis and management-a developing country review", Pediatric Health Med Ther, 11, pp.39~46 (2020)
- 이상준, "재발성 호흡기 유두종증", 대한이비인후-두경부외과학회지, 58(12), pp.822~830 (2015), 대한이비인후과학회[DOI]
- Mitsumoto GL, "Juvenile-onset recurrent respiratory papillomatosis with pulmonary involvement and carcinomatous transformation", Autops Case Rep, 8, pp.e2018035~ (2018)
- Maunsell R, "Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child : case report", Sao Paulo Med J, 136, pp.376~381 (2018)
- Derkay CS, "Recurrent respiratory papillomatosis : a review", Laryngoscope, 118, pp.1236~1247 (2008)
- McGlennen RC, "Pilot trial of ribavirin for the treatment of laryngeal papillomatosis", Head Neck, 15, pp.504~512 (1993)
- Chadha NK, "Antiviral agents for the treatment of recurrent respiratory papillomatosis : a systematic review of the English-language literature", Otolaryngol Head Neck Surg, 136, pp.863~869 (2007)
- Bedoya A, "Systemic bevacizumab for recurrent respiratory papillomatosis : a single center experience of two cases", Am J Case Rep, 18, pp.842~846 (2017)
- Young DL, "The use of the quadrivalent human papillomavirus vaccine(gardasil)as adjuvant therapy in the treatment of recurrent respiratory papilloma", J Voice, 29, pp.223~229 (2015)
- Broekema FI, "Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis", Eur Arch Otorhinolaryngol, 265, pp.871~879 (2008)
- 이진영, "Cidofovir로 치료한 아데노바이러스 폐렴 2예", 대한내과학회지, 70(1), pp.94~100 (2006), 대한내과학회
- 김민경, "BK 바이러스로 인한 출혈성 방광염이 발생한 소아청소년 암환자에서 cidofovir 정맥 및 방광 내 병용요법의 임상적 유효성과 안전성", 병원약사회지, 35(1), pp.9~19 (2018), 한국병원약사회[DOI]
- Van Valckenborgh I, "Systemic cidofovir in papillomatosis", Clin Infect Dis, 32, pp.E62~E64 (2001)
- Gelinas JF, "Lung involvement in juvenile onset recurrent respiratory papillomatosis : a systematic review of the literature", Int J Pediatr Otorhinolaryngol, 72, pp.433~452 (2008)
- Kramer SS, "Pulmonary manifestations of juvenile laryngotracheal papillomatosis", AJR Am J Roentgenol, 144, pp.687~694 (1985)